{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T20:25:13Z","timestamp":1750883113725},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00347-012-2639-3","type":"journal-article","created":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T14:39:25Z","timestamp":1353595165000},"page":"1077-1081","source":"Crossref","is-referenced-by-count":14,"title":["Morphologische Ver\u00e4nderungen durch Konservierungsmittel in Augentropfen"],"prefix":"10.1007","volume":"109","author":[{"given":"K.K.","family":"Huber-van der Velden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Thieme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Eichhorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,21]]},"reference":[{"key":"2639_CR1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/10807680260218498","volume":"18","author":"Acheampong","year":"2002","unstructured":"Acheampong AA, Small D, Baumgarten V et al (2002) Formulation effects on ocular absorption of brimonidine in rabbit eyes. J Ocul Pharmacol Ther 18:325\u2013337","journal-title":"J Ocul Pharmacol Ther"},{"key":"2639_CR2","first-page":"1806","volume":"17","author":"Ammar","year":"2011","unstructured":"Ammar DA, Kahook MY (2011) Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells. Mol Vis 17:1806\u20131813","journal-title":"Mol Vis"},{"key":"2639_CR3","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1136\/bjophthalmol-2011-300012","volume":"95","author":"Ammar","year":"2011","unstructured":"Ammar DA, Kahook MY (2011) Effects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell lines. Br J Ophthalmol 95:1466\u20131469","journal-title":"Br J Ophthalmol"},{"key":"2639_CR4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12325-010-0070-1","volume":"27","author":"Ammar","year":"2010","unstructured":"Ammar DA, Noecker RJ, Kahook MY (2010) Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells. Adv Ther 27:837\u2013845","journal-title":"Adv Ther"},{"key":"2639_CR5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0161-6420(94)31322-4","volume":"101","author":"Baudouin","year":"1994","unstructured":"Baudouin C, Garcher C, Haouat N et al (1994) Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma. Ophthalmology 101:454\u2013460","journal-title":"Ophthalmology"},{"key":"2639_CR6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","volume":"29","author":"Baudouin","year":"2010","unstructured":"Baudouin C, Labbe A, Liang H et al (2010) Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 29:312\u2013334","journal-title":"Prog Retin Eye Res"},{"key":"2639_CR7","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1167\/iovs.07-0266","volume":"48","author":"Baudouin","year":"2007","unstructured":"Baudouin C, Riancho L, Warnet JM et al (2007) In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost. Invest Ophthalmol Vis Sci 48:4123\u20134128","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2639_CR8","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3109\/02713683.2011.578781","volume":"36","author":"Brignole-Baudouin","year":"2011","unstructured":"Brignole-Baudouin F, Riancho L, Liang H et al (2011) Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells. Curr Eye Res 36:979\u2013988","journal-title":"Curr Eye Res"},{"key":"2639_CR9","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1001\/archopht.1994.01090230051020","volume":"112","author":"Broadway","year":"1994","unstructured":"Broadway DC, Grierson I, O\u2019brien C et al (1994) Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch Ophthalmol 112:1437\u20131445","journal-title":"Arch Ophthalmol"},{"key":"2639_CR10","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/archopht.1994.01090230060021","volume":"112","author":"Broadway","year":"1994","unstructured":"Broadway DC, Grierson I, O\u2019brien C et al (1994) Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 112:1446\u20131454","journal-title":"Arch Ophthalmol"},{"key":"2639_CR11","first-page":"308","volume":"19","author":"Burstein","year":"1980","unstructured":"Burstein NL (1980) Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas. Invest Ophthalmol Vis Sci 19:308\u2013313","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2639_CR12","first-page":"619","volume":"40","author":"De","year":"1999","unstructured":"De Saint Jean M, Brignole F, Bringuier AF et al (1999) Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci 40:619\u2013630","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2639_CR13","first-page":"642","volume":"42","author":"Debbasch","year":"2001","unstructured":"Debbasch C, Brignole F, Pisella PJ et al (2001) Quaternary ammoniums and other preservatives\u2018 contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci 42:642\u2013652","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2639_CR14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/1080768041725326","volume":"20","author":"Dong","year":"2004","unstructured":"Dong JQ, Babusis DM, Welty DF et al (2004) Effects of the preservative purite on the bioavailability of brimonidine in the aqueous humor of rabbits. J Ocul Pharmacol Ther 20:285\u2013292","journal-title":"J Ocul Pharmacol Ther"},{"key":"2639_CR15","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00417-008-0881-9","volume":"246","author":"Erb","year":"2008","unstructured":"Erb C, Gast U, Schremmer D (2008) German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye. Graefes Arch Clin Exp Ophthalmol 246:1593\u20131601","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2639_CR16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5301\/ejo.5000001","volume":"22","author":"Gandolfi","year":"2012","unstructured":"Gandolfi S, Paredes T, Goldberg I et al (2012) Comparison of a travoprost BAK-free formulation preserved with polyquaternium-1 with BAK-preserved travoprost in ocular hypertension or open-angle glaucoma. Eur J Ophthalmol 22:34\u201344","journal-title":"Eur J Ophthalmol"},{"key":"2639_CR17","first-page":"613","volume":"2","author":"Henry","year":"2008","unstructured":"Henry JC, Peace JH, Stewart JA et al (2008) Efficacy, safety, and improved tolerability of travoprost BAK-free ophthalmic solution compared with prior prostaglandin therapy. Clin Ophthalmol 2:613\u2013621","journal-title":"Clin Ophthalmol"},{"key":"2639_CR18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0161-6420(92)31847-0","volume":"99","author":"Herreras","year":"1992","unstructured":"Herreras JM, Pastor JC, Calonge M et al (1992) Ocular surface alteration after long-term treatment with an antiglaucomatous drug. Ophthalmology 99:1082\u20131088","journal-title":"Ophthalmology"},{"key":"2639_CR19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00003226-199211030-00006","volume":"11","author":"Ichijima","year":"1992","unstructured":"Ichijima H, Petroll WM, Jester JV et al (1992) Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride. Cornea 11:221\u2013225","journal-title":"Cornea"},{"key":"2639_CR20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/112067210701700311","volume":"17","author":"Jaenen","year":"2007","unstructured":"Jaenen N, Baudouin C, Pouliquen P et al (2007) Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol 17:341\u2013349","journal-title":"Eur J Ophthalmol"},{"key":"2639_CR21","first-page":"43","volume":"40","author":"Jumblatt","year":"1999","unstructured":"Jumblatt MM, Mckenzie RW, Jumblatt JE (1999) MUC5AC mucin is a component of the human precorneal tear film. Invest Ophthalmol Vis Sc 40:43\u201349","journal-title":"Invest Ophthalmol Vis Sc"},{"key":"2639_CR22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/ICO.0b013e31815cf651","volume":"27","author":"Kahook","year":"2008","unstructured":"Kahook MY, Noecker RJ (2008) Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears. Cornea 27:339\u2013343","journal-title":"Cornea"},{"key":"2639_CR23","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/eye.2011.134","volume":"25","author":"Kitazawa","year":"2011","unstructured":"Kitazawa Y, Smith P, Sasaki N et al (2011) Travoprost 0.004%\/timolol 0.5%-fixed combination with and without benzalkonium chloride: a prospective, randomized, doubled-masked comparison of safety and efficacy. Eye 25:1161\u20131169","journal-title":"Eye"},{"key":"2639_CR24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/jop.2006.22.267","volume":"22","author":"Labbe","year":"2006","unstructured":"Labbe A, Pauly A, Liang H et al (2006) Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study. J Ocul Pharmacol Ther 22:267\u2013278","journal-title":"J Ocul Pharmacol Ther"},{"key":"2639_CR25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/01.ijg.0000212274.50229.c6","volume":"16","author":"Lewis","year":"2007","unstructured":"Lewis RA, Katz GJ, Weiss MJ et al (2007) Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy. J Glaucoma 16:98\u2013103","journal-title":"J Glaucoma"},{"key":"2639_CR26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/bjo.2008.138768","volume":"92","author":"Liang","year":"2008","unstructured":"Liang H, Baudouin C, Pauly A et al (2008) Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride. Br J Ophthalmol 92:1275\u20131282","journal-title":"Br J Ophthalmol"},{"key":"2639_CR27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12325-011-0003-7","volume":"28","author":"Liang","year":"2011","unstructured":"Liang H, Brignole-Baudouin F, Pauly A et al (2011) Polyquad-preserved travoprost\/timolol, benzalkonium chloride (BAK)-preserved travoprost\/timolol, and latanoprost\/timolol in fixed combinations: a rabbit ocular surface study. Adv Ther 28:311\u2013325","journal-title":"Adv Ther"},{"key":"2639_CR28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF00182000","volume":"232","author":"Mietz","year":"1994","unstructured":"Mietz H, Niesen U, Krieglstein GK (1994) The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva. Graefes Arch Clin Exp Ophthalmol 232:561\u2013565","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2639_CR29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02849799","volume":"20","author":"Mundorf","year":"2003","unstructured":"Mundorf T, Wilcox KA, Ousler GW 3rd et al (2003) Evaluation of the comfort of Alphagan P compared with Alphagan in irritated eyes. Adv Ther 20:329\u2013336","journal-title":"Adv Ther"},{"key":"2639_CR30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.ico.0000116526.57227.82","volume":"23","author":"Noecker","year":"2004","unstructured":"Noecker RJ, Herrygers LA, Anwaruddin R (2004) Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea 23:490\u2013496","journal-title":"Cornea"},{"key":"2639_CR31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF00166608","volume":"233","author":"Nuzzi","year":"1995","unstructured":"Nuzzi R, Vercelli A, Finazzo C et al (1995) Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study. Graefes Arch Clin Exp Ophthalmol 233:154\u2013162","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2639_CR32","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1167\/iovs.03-1067","volume":"45","author":"Pisella","year":"2004","unstructured":"Pisella P-J, Debbasch C, Hamard P et al (2004) Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Invest Ophthalmol Vis Sci 45:1360\u20131368","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2639_CR33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1208\/pt070357","volume":"7","author":"Rathore","year":"2006","unstructured":"Rathore MS, Majumdar DK (2006) Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops. AAPS PharmSciTech 7:57","journal-title":"AAPS PharmSciTech"},{"key":"2639_CR34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1089\/jop.2008.0017","volume":"24","author":"Romanowski","year":"2008","unstructured":"Romanowski EG, Mah FS, Kowalski RP et al (2008) Benzalkonium chloride enhances the antibacterial efficacy of gatifloxacin in an experimental rabbit model of intrastromal keratitis. J Ocul Pharmacol Ther 24:380\u2013384","journal-title":"J Ocul Pharmacol Ther"},{"key":"2639_CR35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2415-11-8","volume":"11","author":"Ryan","year":"2011","unstructured":"Ryan G Jr, Fain JM, Lovelace C et al (2011) Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative system. BMC Ophthalmol 11:8","journal-title":"BMC Ophthalmol"},{"key":"2639_CR36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0161-6420(89)32888-0","volume":"96","author":"Sherwood","year":"1989","unstructured":"Sherwood MB, Grierson I, Millar L et al (1989) Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon\u2019s capsule in glaucomatous patients. Ophthalmology 96:327\u2013335","journal-title":"Ophthalmology"},{"key":"2639_CR37","first-page":"865","volume":"88","author":"Steuhl","year":"1991","unstructured":"Steuhl KP, Knorr M, Frohn A et al (1991) Uber den Einfluss antiglaukomat\u00f6ser Augentropfen auf die Zelldifferenzierung der Konjunktiva. Fortschr Ophthalmol 88:865\u2013869","journal-title":"Fortschr Ophthalmol"},{"key":"2639_CR38","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1167\/iovs.07-0720","volume":"49","author":"Xiong","year":"2008","unstructured":"Xiong C, Chen D, Liu J et al (2008) a rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride. Invest Ophthalmol Vis Sci 49:1850\u20131856","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-012-2639-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-012-2639-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-012-2639-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T19:42:06Z","timestamp":1562355726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-012-2639-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["2639"],"URL":"https:\/\/doi.org\/10.1007\/s00347-012-2639-3","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}